Endo International Plc (ENDP)

3.27
0.07 2.10
NASDAQ : Health Technology
Prev Close 3.34
Open 3.33
Day Low/High 3.21 / 3.40
52 Wk Low/High 3.25 / 18.50
Volume 4.75M
Avg Volume 4.30M
Exchange NASDAQ
Shares Outstanding 226.18M
Market Cap 791.64M
EPS -4.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Endo To Announce Second-Quarter 2019 Financial Results

Endo To Announce Second-Quarter 2019 Financial Results

DUBLIN, July 11, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) will announce its second-quarter 2019 financial results on August 6, 2019 and members of its senior management team will host a conference call and webcast at 7:30 a.

August 23rd Options Now Available For Endo International (ENDP)

August 23rd Options Now Available For Endo International (ENDP)

Investors in Endo International plc saw new options become available today, for the August 23rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new August 23rd contracts and identified one put and one call contract of particular interest.

August 9th Options Now Available For Endo International (ENDP)

August 9th Options Now Available For Endo International (ENDP)

Investors in Endo International plc saw new options become available today, for the August 9th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new August 9th contracts and identified one put and one call contract of particular interest.

Interesting ENDP Put And Call Options For August 16th

Interesting ENDP Put And Call Options For August 16th

Investors in Endo International plc saw new options become available this week, for the August 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new August 16th contracts and identified one put and one call contract of particular interest.

ENDP August 2nd Options Begin Trading

ENDP August 2nd Options Begin Trading

Investors in Endo International plc saw new options begin trading today, for the August 2nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new August 2nd contracts and identified one put and one call contract of particular interest.

Nationally Recognized Urologist And Author, Aaron Spitz, MD, Teams Up With Endo Pharmaceuticals' Ask About The Curve Campaign To Encourage Men To Get "In Touch" With Their Anatomy This Men's Health Month

Nationally Recognized Urologist And Author, Aaron Spitz, MD, Teams Up With Endo Pharmaceuticals' Ask About The Curve Campaign To Encourage Men To Get "In Touch" With Their Anatomy This Men's Health Month

DUBLIN and MALVERN, Pa., June 6, 2019 /PRNewswire/ -- Ask About the Curve raises awareness of Peyronie's disease, a men's health condition that may affect about 1 in 10 men and leads to a pronounced curvature in the penis and potential pain during arousal.

July 5th Options Now Available For Endo International (ENDP)

July 5th Options Now Available For Endo International (ENDP)

Investors in Endo International plc saw new options begin trading today, for the July 5th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new July 5th contracts and identified one put and one call contract of particular interest.

Phase 3 Data Of Collagenase Clostridium Histolyticum For The Investigational Treatment Of Cellulite To Be Presented At The Aesthetic Meeting 2019

Phase 3 Data Of Collagenase Clostridium Histolyticum For The Investigational Treatment Of Cellulite To Be Presented At The Aesthetic Meeting 2019

Clinical Investigator Dr. Lawrence Bass is a Featured Hot Topics Speaker DUBLIN, May 17, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that clinical data from a Phase 3 investigational study of collagenase clostridium...

Endo To Participate At RBC Healthcare Conference

Endo To Participate At RBC Healthcare Conference

DUBLIN, May 15, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the RBC Annual Healthcare Conference in New York City on Tuesday, May 21, 2019 at 10:00 a.

Endo Pharmaceutical Falls After Downgrade to Underweight at JPMorgan

Endo Pharmaceutical Falls After Downgrade to Underweight at JPMorgan

Endo Pharmaceutical is downgraded to underweight from neutral at JPMorgan.

Endo Reports First-Quarter 2019 Financial Results

Endo Reports First-Quarter 2019 Financial Results

DUBLIN, May 9, 2019 /PRNewswire/ -- First-quarter 2019 revenues increased 3 percent to $720 million compared to first-quarter 2018 revenues of $701 million First-quarter 2019 Sterile Injectables revenues increased 25 percent to $270 million compared to...

Interesting ENDP Put And Call Options For June 14th

Interesting ENDP Put And Call Options For June 14th

Investors in Endo International plc saw new options begin trading today, for the June 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new June 14th contracts and identified one put and one call contract of particular interest.

Par Pharmaceutical, Inc. Issues Voluntary Nationwide Recall Of One Lot Of Mycophenolate Mofetil For Injection, USP Due To The Presence Of A Glass Fragment Observed In One Vial Of Reconstituted Product

Par Pharmaceutical, Inc. Issues Voluntary Nationwide Recall Of One Lot Of Mycophenolate Mofetil For Injection, USP Due To The Presence Of A Glass Fragment Observed In One Vial Of Reconstituted Product

DUBLIN, May 1, 2019 /PRNewswire/ -- Endo International plc, announced today that one of its operating companies, Par Pharmaceutical, Inc.

Endo To Announce First-Quarter 2019 Financial Results

Endo To Announce First-Quarter 2019 Financial Results

DUBLIN, April 10, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) will announce its first-quarter 2019 financial results on May 9, 2019 and members of its senior management team will host a conference call and webcast at 7:30 a.

Endo Begins Shipment Of Authorized Generic Version Of PROVENTIL® (albuterol Sulfate) HFA Inhalation Aerosol In The United States

Endo Begins Shipment Of Authorized Generic Version Of PROVENTIL® (albuterol Sulfate) HFA Inhalation Aerosol In The United States

DUBLIN , April 5, 2019 /PRNewswire/ --  Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical (Par), has begun shipping an authorized generic version of Merck's PROVENTIL ® (albuterol sulfate)...

Endo International Plc Announces Early Tender Results Of Its Previously Announced Cash Tender Offers And Consent Solicitations For Up To $1.5 Billion Aggregate Purchase Price Of Its Outstanding Senior Notes

Endo International Plc Announces Early Tender Results Of Its Previously Announced Cash Tender Offers And Consent Solicitations For Up To $1.5 Billion Aggregate Purchase Price Of Its Outstanding Senior Notes

DUBLIN, March 27, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (the "Company" or "Endo")  today announced the early tender results of the previously announced cash tender offers (the "Tender Offers") made by Endo Finance LLC ("Endo...

First Week Of ENDP May 17th Options Trading

First Week Of ENDP May 17th Options Trading

Investors in Endo International plc saw new options begin trading this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new May 17th contracts and identified one put and one call contract of particular interest.

Endo Announces Publication Of Collagenase Clostridium Histolyticum (CCH) Phase 2 Data In Dermatologic Surgery

Endo Announces Publication Of Collagenase Clostridium Histolyticum (CCH) Phase 2 Data In Dermatologic Surgery

Leading Peer-Reviewed Dermatology Journal Features Phase 2 Data DUBLIN, March 19, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced the publication of Phase 2 data evaluating collagenase clostridium histolyticum (or "CCH") for the...

Endo International Plc Announces An Upsizing Of Its Cash Tender Offers And Consent Solicitations

Endo International Plc Announces An Upsizing Of Its Cash Tender Offers And Consent Solicitations

DUBLIN, March 14, 2019 /PRNewswire/ --  Endo International plc (NASDAQ: ENDP) today announced an upsizing of its previously announced cash tender offers (the "Tender Offers") and consent solicitations by Endo Finance LLC ("Endo Finance"), a wholly-owned...

Endo International Plc Announces Pricing Of Private Offering Of Senior Secured Notes

Endo International Plc Announces Pricing Of Private Offering Of Senior Secured Notes

DUBLIN, March 14, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) ("Endo") today announced that Par Pharmaceutical, Inc.

Endo International Plc Announces Debt Refinancing Transactions, Including Cash Tender Offers And Consent Solicitations For Up To $1.0 Billion Aggregate Purchase Price Of Its Outstanding Senior Notes

Endo International Plc Announces Debt Refinancing Transactions, Including Cash Tender Offers And Consent Solicitations For Up To $1.0 Billion Aggregate Purchase Price Of Its Outstanding Senior Notes

DUBLIN, March 14, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced a series of debt refinancing transactions that are intended to help manage the debt maturity profile of it and certain of its subsidiaries (collectively, the...

Endo International Plc Announces Proposed Private Offering Of Senior Secured Notes

Endo International Plc Announces Proposed Private Offering Of Senior Secured Notes

DUBLIN, March 14, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) ("Endo") today announced that Par Pharmaceutical, Inc.

Endo To Participate At Cowen & Company 39th Annual Healthcare Conference

Endo To Participate At Cowen & Company 39th Annual Healthcare Conference

DUBLIN, March 4, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) announced today that members of management will participate in a fireside chat at the Cowen & Company 39 th Annual Healthcare Conference in Boston, Massachusetts on Monday, March...

Endo Announces FDA Decision Not To Include Vasopressin On 503B Bulks List

Endo Announces FDA Decision Not To Include Vasopressin On 503B Bulks List

DUBLIN, March 1, 2019 /PRNewswire/ --  Endo International plc ("Endo") (NASDAQ: ENDP) today announced that the U.

Endo Will Showcase Late-Breaking Phase 3 CCH Data At The 2019 American Academy Of Dermatology Annual Meeting

Endo Will Showcase Late-Breaking Phase 3 CCH Data At The 2019 American Academy Of Dermatology Annual Meeting

Endo To Present Data From Two Abstracts on Collagenase Clostridium Histolyticum DUBLIN, March 1, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that it will present new data showing collagenase clostridium histolyticum (CCH)...

Endo Reports Fourth-Quarter And Full Year 2018 Financial Results

Endo Reports Fourth-Quarter And Full Year 2018 Financial Results

DUBLIN, Feb. 28, 2019 /PRNewswire/ -- Fourth-quarter 2018 revenues increased 2 percent to $786 million Fourth-quarter 2018 Sterile Injectables revenues increased 32 percent to $259 million Fourth-quarter 2018 XIAFLEX ® franchise revenues increased 30...

Endo Announces Termination Of Acquisition Agreements With Somerset Therapeutics And Business Of Affiliate Wintac Limited

Endo Announces Termination Of Acquisition Agreements With Somerset Therapeutics And Business Of Affiliate Wintac Limited

DUBLIN, Feb. 27, 2019 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that its subsidiaries, Endo Ventures Limited, Par Pharmaceutical, Inc.

3 Small Biotechs to Watch as Earnings Season Winds Down

3 Small Biotechs to Watch as Earnings Season Winds Down

One already is up nicely on its results, while the other two should issue reports of interest in the next few days.

TheStreet Quant Rating: D (Sell)